| Notas: | 1. Tumor Markers in Detection of Lung Cancer. 2. Advances in serum protein electrophoresis. 3. Aspirin resistance: A review of diagnostic methodology, mechanisms and clinical utility. 4. Vitreous Fluid Biomarkers. 5. Tumor-associated carbonic anhydrases and their clinical significance. 6. Mitochondrial disease: maintenance of mitochondrial genome and molecular diagnotics. 7. Microfluidic Enzyme-Linked Immunosorbent Assay (ELISA) Technology. 8. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prelevance and clinical relevance. |
|---|
